Every SEC Form 3/4/5 on record for this filer (CIK 1164426) — 52 issuers, 94 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LONA | LeonaBio, Inc. | Director | 2026-04-13 → 2026-06-24 | 2 | — |
| KARD | Kardigan, Inc. | Director | 2026-06-18 → 2026-06-18 | 1 | — |
| MGTX | MeiraGTx Holdings plc | Director | 2018-06-08 → 2026-06-15 | 17 | $15M |
| SLDB | Solid Biosciences Inc. | Director | 2018-01-25 → 2026-06-11 | 18 | $35M |
| IMTX | Immatics N.V. | Director | 2026-03-18 → 2026-03-18 | 1 | — |
| ATHA | Athira Pharma, Inc. | Director | 2020-09-17 → 2025-12-23 | 11 | $31M |
| LYRA | Lyra Therapeutics, Inc. | 10% owner | 2020-04-30 → 2025-11-13 | 8 | −$344,291 |
| ADGM | Adagio Medical Holdings, Inc. | 10% owner | 2024-08-01 → 2025-10-22 | 3 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | 10% owner | 2024-07-17 → 2025-08-05 | 2 | — |
| ACRV | Acrivon Therapeutics, Inc. | 10% owner | 2022-11-18 → 2025-05-01 | 4 | — |
| ALDX | Aldeyra Therapeutics, Inc. | 10% owner | 2015-10-22 → 2025-04-07 | 26 | $15M |
| ARYD | ARYA Sciences Acquisition Corp IV | Director | 2021-02-25 → 2024-07-31 | 2 | — |
| VAPO | VAPOTHERM INC | 10% owner · lapsed | 2024-06-27 → 2024-06-27 | 1 | — |
| NAUT | Nautilus Biotechnology, Inc. | Director · lapsed | 2021-06-11 → 2024-06-17 | 5 | — |
| PCSC | Perceptive Capital Solutions Corp | Director · lapsed | 2024-06-11 → 2024-06-11 | 1 | — |
| CERE | Cerevel Therapeutics Holdings, Inc. | Director · lapsed | 2020-10-29 → 2024-02-21 | 7 | $22M |
| LIAN | LianBio | Director · lapsed | 2021-10-29 → 2024-02-20 | 9 | — |
| ATXS | Astria Therapeutics, Inc. | Director · lapsed | 2022-12-21 → 2024-02-05 | 4 | — |
| VRCA | Verrica Pharmaceuticals Inc. | 10% owner · lapsed | 2018-08-01 → 2023-12-29 | 6 | $2M |
| CRGX | CARGO Therapeutics, Inc. | Filer · lapsed | 2023-11-09 → 2023-11-14 | 2 | $10M |
| SLNO | SOLENO THERAPEUTICS INC | 10% owner · lapsed | 2023-05-18 → 2023-09-28 | 6 | $449,825 |
| CEMI | CHEMBIO DIAGNOSTICS, INC. | Filer · lapsed | 2023-04-06 → 2023-05-01 | 7 | $109,552 |
| VBIV | VBI Vaccines Inc/BC | 10% owner · lapsed | 2015-08-18 → 2023-04-06 | 13 | $1M |
| LABP | Landos Biopharma, Inc. | 10% owner · lapsed | 2021-02-03 → 2023-01-11 | 5 | — |
| QTNT | Quotient Ltd | 10% owner · lapsed | 2017-10-26 → 2022-11-02 | 8 | $18M |
| ALBO | ALBIREO PHARMA, INC. | 10% owner · lapsed | 2017-12-04 → 2022-10-13 | 5 | $9M |
| CRNX | Crinetics Pharmaceuticals, Inc. | 10% owner · lapsed | 2018-07-17 → 2022-04-18 | 7 | $24M |
| AGRX | AGILE THERAPEUTICS INC | 10% owner · lapsed | 2018-03-28 → 2021-10-15 | 10 | $10M |
| ISO | IsoPlexis Corp | 10% owner · lapsed | 2021-10-07 → 2021-10-14 | 2 | $13M |
| RAIN | Rain Enhancement Technologies Holdco, Inc. | 10% owner · lapsed | 2021-04-22 → 2021-10-13 | 3 | −$667,479 |
| ADMA | ADMA BIOLOGICS, INC. | 10% owner · lapsed | 2017-11-15 → 2021-09-30 | 8 | $15M |
| LPTX | LEAP THERAPEUTICS, INC. | 10% owner · lapsed | 2020-04-20 → 2021-09-28 | 3 | — |
| VYNE | VYNE Therapeutics Inc. | 10% owner · lapsed | 2021-02-01 → 2021-08-18 | 5 | −$4M |
| ARYE | ARYA Sciences Acquisition Corp V | Director · lapsed | 2021-07-12 → 2021-07-12 | 1 | — |
| ARYA | ARYA Sciences Acquisition Corp III | Director · lapsed | 2018-10-05 → 2021-06-03 | 4 | — |
| RXDX | Prometheus Biosciences, Inc. | 10% owner · lapsed | 2021-03-11 → 2021-03-16 | 2 | — |
| CATB | CATABASIS PHARMACEUTICALS INC | Director · lapsed | 2021-02-03 → 2021-02-03 | 2 | — |
| SCYX | SCYNEXIS INC | 10% owner · lapsed | 2021-01-26 → 2021-01-26 | 2 | — |
| MOTS | Motus GI Holdings, Inc. | 10% owner · lapsed | 2018-02-13 → 2021-01-22 | 6 | $4M |
| ARYB | ARYA Sciences Acquisition Corp II | Director · lapsed | 2020-06-04 → 2020-10-22 | 2 | — |
| ATNX | Athenex, Inc. | 10% owner · lapsed | 2019-05-08 → 2020-09-14 | 15 | $5M |
| MNLO | Menlo Therapeutics Inc. | Director · lapsed | 2020-06-11 → 2020-06-11 | 2 | — |
| KDMN | Kadmon Holdings, Inc. | 10% owner · lapsed | 2017-03-20 → 2019-11-18 | 3 | $5M |
| DOVA | Dova Pharmaceuticals Inc. | 10% owner · lapsed | 2018-06-06 → 2019-11-15 | 12 | $1M |
| FOMX | Foamix Pharmaceuticals Ltd. | 10% owner · lapsed | 2019-08-06 → 2019-08-06 | 1 | — |
| FOLD | AMICUS THERAPEUTICS, INC. | 10% owner · lapsed | 2015-10-07 → 2019-02-19 | 18 | $9M |
| LJPC | LA JOLLA PHARMACEUTICAL CO | 10% owner · lapsed | 2017-12-18 → 2019-01-09 | 5 | — |
| CORI | Corium International, Inc. | 10% owner · lapsed | 2017-05-25 → 2018-10-15 | 5 | $2M |
| ZGNX | ZOGENIX, INC. | 10% owner · lapsed | 2017-05-18 → 2018-08-14 | 5 | $3M |
| GBT | Global Blood Therapeutics, Inc. | Filer · lapsed | 2017-12-15 → 2018-07-25 | 3 | — |
| VSAR | Versartis, Inc. | 10% owner · lapsed | 2016-09-28 → 2017-09-25 | 9 | $1M |
| ACRX | ACELRX PHARMACEUTICALS INC | 10% owner · lapsed | 2015-09-11 → 2017-06-21 | 6 | −$849,564 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LYRA | 2025-11-10 | Sell | 16,633 | $4.54 | $75,514 | 166,101 |
| LYRA | 2025-11-10 | Sell | 1,869 | $4.54 | $8,485 | 18,659 |
| LYRA | 2025-11-07 | Sell | 17,746 | $4.75 | $84,294 | 182,734 |
| LYRA | 2025-11-07 | Sell | 1,993 | $4.75 | $9,467 | 20,528 |
| LYRA | 2025-11-06 | Sell | 3,247 | $5.18 | $16,819 | 22,521 |
| LYRA | 2025-11-06 | Sell | 28,902 | $5.18 | $149,712 | 200,480 |
| SLDB | 2025-02-19 | Buy | 5,000,000 | $4.03 | $20M | 11,833,539 |
| MGTX | 2024-08-12 | Buy | 1,250,000 | $4.00 | $5M | 12,531,103 |
| ALDX | 2024-04-05 | Buy | 37,712 | $4.74 | $178,755 | 9,275,851 |
| ALDX | 2024-04-04 | Buy | 140,281 | $4.67 | $655,112 | 9,238,139 |
15 of 52 issuers are covered and open a security page; the rest are on file here only.
